Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

VCYT – Veracyte, Inc.

Veracyte, Inc.
VCYT
$34.61
Name : Veracyte, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $2,835,324,160.00
EPSttm : 0.34
finviz dynamic chart for VCYT
Veracyte, Inc.
$34.61
3.97%
$1.43

Float Short %

11.87

Margin Of Safety %

-16

Put/Call OI Ratio

0.15

EPS Next Q Diff

-0.07

EPS Last/This Y

1.11

EPS This/Next Y

0.01

Price

34.62

Target Price

42.11

Analyst Recom

1.55

Performance Q

27.81

Relative Volume

0.53

Beta

2.16

Ticker: VCYT




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-09-08VCYT32.470.200.161731
2025-09-09VCYT31.990.200.121738
2025-09-10VCYT30.90.200.801756
2025-09-11VCYT31.860.200.711756
2025-09-12VCYT30.880.192.151747
2025-09-15VCYT31.870.210.641787
2025-09-16VCYT32.270.210.331808
2025-09-17VCYT31.830.212182061579650.034482758620691811
2025-09-18VCYT33.240.213.001816
2025-09-22VCYT33.950.170.091429
2025-09-23VCYT34.180.172.251441
2025-09-24VCYT32.650.161.251434
2025-09-25VCYT32.820.170.001440
2025-09-26VCYT33.430.16999.991442
2025-09-29VCYT33.640.160.251436
2025-09-30VCYT34.340.160.001437
2025-10-01VCYT36.220.160.001429
2025-10-02VCYT35.610.160.001459
2025-10-03VCYT36.010.150.001468
2025-10-06VCYT36.040.150.001482
2025-10-07VCYT34.630.15999.991492
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-09-08VCYT32.46-3.589.71.43
2025-09-09VCYT31.97-3.587.51.43
2025-09-10VCYT30.81-3.584.61.43
2025-09-11VCYT31.86-3.594.01.43
2025-09-12VCYT30.88-3.585.41.43
2025-09-15VCYT31.88-3.593.81.43
2025-09-16VCYT32.28-3.591.21.43
2025-09-17VCYT31.83-3.587.71.43
2025-09-18VCYT33.25-3.595.41.43
2025-09-19VCYT34.12-3.593.11.43
2025-09-22VCYT33.93-3.588.81.43
2025-09-23VCYT34.18-3.590.51.43
2025-09-24VCYT32.63-3.583.71.43
2025-09-25VCYT32.82-3.590.11.43
2025-09-26VCYT33.44-3.592.01.43
2025-09-29VCYT33.64-3.590.31.43
2025-09-30VCYT34.31-3.592.31.43
2025-10-01VCYT36.22-3.596.91.43
2025-10-02VCYT35.62-3.587.41.43
2025-10-03VCYT36.01-3.590.91.43
2025-10-06VCYT36.05-3.591.11.43
2025-10-07VCYT34.62-3.584.41.43
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-09-08VCYT-1.487.0110.61
2025-09-09VCYT-1.487.0110.61
2025-09-10VCYT-1.487.0110.61
2025-09-11VCYT-1.097.0110.46
2025-09-12VCYT-1.097.0110.46
2025-09-15VCYT-1.107.0710.46
2025-09-16VCYT-1.107.0710.46
2025-09-17VCYT-1.107.0710.46
2025-09-18VCYT-1.107.0710.46
2025-09-19VCYT-1.107.0710.46
2025-09-22VCYT-1.107.0810.46
2025-09-23VCYT-1.227.0810.46
2025-09-24VCYT-1.227.0810.46
2025-09-25VCYT-1.227.0811.87
2025-09-26VCYT-1.227.0811.87
2025-09-29VCYT-1.227.0611.87
2025-09-30VCYT-1.227.0611.87
2025-10-01VCYT-1.227.0611.87
2025-10-02VCYT-1.227.0611.87
2025-10-03VCYT-2.657.0611.87
2025-10-06VCYT-2.658.0611.87
2025-10-07VCYT-3.098.0611.87
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.44

Avg. EPS Est. Current Quarter

0.32

Avg. EPS Est. Next Quarter

0.37

Insider Transactions

-3.09

Institutional Transactions

8.06

Beta

2.16

Average Sales Estimate Current Quarter

124

Average Sales Estimate Next Quarter

131

Fair Value

29.11

Quality Score

85

Growth Score

70

Sentiment Score

92

Actual DrawDown %

59.8

Max Drawdown 5-Year %

-81.2

Target Price

42.11

P/E

104.03

Forward P/E

23.73

PEG

1.42

P/S

5.68

P/B

2.23

P/Free Cash Flow

32.43

EPS

0.33

Average EPS Est. Cur. Y​

1.43

EPS Next Y. (Est.)

1.44

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.5

Relative Volume

0.53

Return on Equity vs Sector %

-23

Return on Equity vs Industry %

-8.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

84.4
Veracyte, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 824
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
stock quote shares VCYT – Veracyte, Inc. Stock Price stock today
news today VCYT – Veracyte, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VCYT – Veracyte, Inc. yahoo finance google finance
stock history VCYT – Veracyte, Inc. invest stock market
stock prices VCYT premarket after hours
ticker VCYT fair value insiders trading